{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:00:13Z","timestamp":1761843613409},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1053\/j.gastro.2007.01.017","type":"journal-article","created":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T14:42:55Z","timestamp":1172155375000},"page":"790-794","source":"Crossref","is-referenced-by-count":17,"title":["Selective COX-2 Inhibitors: A Promise Unfulfilled?"],"prefix":"10.1053","volume":"132","author":[{"given":"David","family":"Henry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"McGettigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2007.01.017_bib1","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","article-title":"Risk of serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis","volume":"115","author":"Gabriel","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2007.01.017_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9343(88)90249-5","article-title":"Ulcer complications and nonsteroidal anti-inflammatory drugs","volume":"84","author":"Langman","year":"1988","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2007.01.017_bib3","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archinte.152.6.1289","article-title":"The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti- inflammatory drugs on upper gastrointestinal tract disease","volume":"152","author":"Bollini","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2007.01.017_bib4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(86)92927-2","article-title":"Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer","volume":"1","author":"Somerville","year":"1986","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2007.01.017_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0016-5085(82)90029-4","article-title":"Inadequacy of the literature on the relationship between drugs ulcers and gastrointestinal bleeding","volume":"82","author":"Kurata","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2007.01.017_bib6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0016-5085(93)90277-J","article-title":"The impact of rising use of non-steroidal anti-inflammatory drugs on peptic ulcer hospitalisation rates in New South Wales, Australia","volume":"104","author":"Henry","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2007.01.017_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-114-4-257","article-title":"Non-steroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons","volume":"114","author":"Griffin","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2007.01.017_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.5694\/j.1326-5377.1996.tb122200.x","article-title":"Pattern of non-steroidal anti-inflammatory drug use in Australia 1990\u20131994","volume":"164","author":"McManus","year":"1996","journal-title":"Med J Aust"},{"key":"10.1053\/j.gastro.2007.01.017_bib9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(94)91843-0","article-title":"Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs","volume":"343","author":"Garcia Rodriguez","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2007.01.017_bib10","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/bmj.312.7046.1563","article-title":"Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis","volume":"312","author":"Henry","year":"1996","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2007.01.017_bib11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00001648-200109000-00018","article-title":"Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs","volume":"12","author":"Garc\u00eda Rodr\u00edguez","year":"2001","journal-title":"Epidemiology"},{"key":"10.1053\/j.gastro.2007.01.017_bib12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/bmj.38232.680567.EB","article-title":"The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review","volume":"329","author":"Hooper","year":"2004","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2007.01.017_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/07853890600925843","article-title":"Prevention of anti-inflammatory drug-induced damage: benefits and risks of therapeutic strategies","volume":"38","author":"Lanas","year":"2006","journal-title":"Ann Med"},{"key":"10.1053\/j.gastro.2007.01.017_bib14","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/art.20440","article-title":"The rise and decline of nonsteroidal anti-inflammatory drug-associated gastropathy in rheumatoid arthritis","volume":"50","author":"Fries","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.gastro.2007.01.017_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","article-title":"Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities","volume":"116","author":"Grosser","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1053\/j.gastro.2007.01.017_bib16","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/jama.282.20.1929","article-title":"Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs","volume":"282","author":"Langman","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2007.01.017_bib17","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2007.01.017_bib18","unstructured":"Celebrex capsules (Celecoxib). NDA 20-998\/S-009: medical officer review. Available from: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/01\/briefing\/3677b1_03_med.pdf. Accessed December 12, 2006."},{"key":"10.1053\/j.gastro.2007.01.017_bib19","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/rheumatology\/37.9.946","article-title":"Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis","volume":"37","author":"Dequeker","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1053\/j.gastro.2007.01.017_bib20","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/rheumatology\/37.9.937","article-title":"Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients","volume":"37","author":"Hawkey","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1053\/j.gastro.2007.01.017_bib21","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2007.01.017_bib22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7326\/0003-4819-139-7-200310070-00005","article-title":"Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial","volume":"139","author":"Lisse","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2007.01.017_bib23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(04)16893-1","article-title":"Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial","volume":"364","author":"Schnitzer","year":"2004","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2007.01.017_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.amjmed.2005.09.054","article-title":"Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study","volume":"119","author":"Singh","year":"2006","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2007.01.017_bib25","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(06)69666-9","article-title":"Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison","volume":"368","author":"Cannon","year":"2006","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2007.01.017_bib26","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis?","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2007.01.017_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1742-7843.2006.pto_302.x","article-title":"Non-steroidal anti-inflammatory drugs and the risk of acute myocardial infarction","volume":"98","author":"Hern\u00e1ndez-D\u00edaz","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1053\/j.gastro.2007.01.017_bib28","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and non-selective inhibitors of cyclooxygenase-2","volume":"296","author":"McGettigan","year":"2006","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2007.01.017_bib29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/j.gastro.2006.11.012","article-title":"Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial","volume":"132","author":"Lanas","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2007.01.017_bib30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1053\/j.gastro.2006.12.007","article-title":"Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population","volume":"132","author":"Garc\u00eda Rodr\u00edguez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2007.01.017_bib31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa061355","article-title":"Celecoxib for the prevention of sporadic colorectal adenomas","volume":"355","author":"Bertagnolli","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2007.01.017_bib32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa061652","article-title":"Celecoxib for the prevention of colorectal adenomatous polyps","volume":"355","author":"Arber","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2007.01.017_bib33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0149-2918(00)89009-8","article-title":"Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease","volume":"22","author":"Degner","year":"2000","journal-title":"Clin Ther"},{"key":"10.1053\/j.gastro.2007.01.017_bib34","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00001648-200109000-00018","article-title":"Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs","volume":"12","author":"Garcia Rodriguez","year":"2001","journal-title":"Epidemiology"},{"key":"10.1053\/j.gastro.2007.01.017_bib35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.325.7365.624","article-title":"Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs","volume":"325","author":"Mamdani","year":"2002","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2007.01.017_bib36","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.52.9.1265","article-title":"Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs","volume":"52","author":"MacDonald","year":"2003","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2007.01.017_bib37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1365-2036.2004.01913.x","article-title":"COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study","volume":"19","author":"Norgard","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2007.01.017_bib38","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/bmj.331.7528.1310","article-title":"Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis","volume":"331","author":"Hippisley-COX","year":"2005","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2007.01.017_bib39","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2005.080754","article-title":"Asociacion Espanola de Gastroenterlogia","volume":"55","author":"Lanas","year":"2006","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2007.01.017_bib40","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1111\/j.1572-0241.2006.00825.x","article-title":"30-day mortality after peptic ulcer perforation among users of newer selective COX-2 inhibitors and traditional NSAIDs: A population-based study","volume":"101","author":"Thomsen","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2007.01.017_bib41","first-page":"1015","volume":"29","author":"Wolfe","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1053\/j.gastro.2007.01.017_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","article-title":"Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis","volume":"359","author":"Huang","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2007.01.017_bib43","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1365-2036.2005.02444.x","article-title":"Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users","volume":"21","author":"Vergara","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2007.01.017_bib44","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1056\/NEJMoa021907","article-title":"Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis","volume":"347","author":"Chan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2007.01.017_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/gut.46.1.27","article-title":"Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs","volume":"46","author":"Weil","year":"2000","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2007.01.017_bib46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11938-006-0033-4","article-title":"Prevention and treatment of NSAID-induced gastroduodenal injury","volume":"9","author":"Lanas","year":"2006","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1053\/j.gastro.2007.01.017_bib47","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.296.13.jed60058","article-title":"COX-2 inhibitors, other NSAIDs, and cardiovascular risk: the seduction of common sense","volume":"296","author":"Graham","year":"2006","journal-title":"JAMA"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508507001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508507001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T05:46:47Z","timestamp":1587361607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508507001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0016508507001278"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2007.01.017","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}